Intalight Reference Database Protocol for VG200D
1 other identifier
observational
350
1 country
3
Brief Summary
The goal of this study is to collect OCT scans on normal healthy eyes from an investigational OCT device the VG200D from Intalight, Inc, in order to establish a reference database. The reference database will be used to establish normal ranges for thickness measurement parameters provided by the VG200D OCT software including anterior segment and posterior segment measurements. The study will enroll normal eyes from three clinics in the US including a wide range of ages and races/ethnicities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 8, 2026
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
August 7, 2026
August 1, 2026
2 months
August 3, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantitative ocular structures
Retinal structural measurements of the anterior and posterior segments of the eye
this study will alst approximately 6 months
Study Arms (1)
Normal
This group includes subjects with normal healthy eyes as confirmed by a clinical examination by trained eye-care professionals
Interventions
Eligibility Criteria
A total of approximately 350 subjects without ocular pathology will be enrolled in this study from 3 clinical sites. Subjects will include a diverse range of races and ethnicities and should reflect or generally approximate the general population of the US. The average age of all subjects will be approximately 55-60 years of age or older. The age distribution will be similar to the table below. Percent 5 10 20 25 25 15 Total # 18 35 70 87 88 52 Age 22-30 31-40 41-50 51-60 61-70 71+ Table1. The age distribution of the study participants along with the percentage for each age group and the total number of subjects for each age group to be enrolled. The following seven categories on race and ethnicity were identified and defined and will be used in this study\*: * American Indian or Alaska Native * Asian * Black or African American * Hispanic or Latino * Middle Eastern or North African * Native Hawaiian or Pacific Islander * White
You may qualify if:
- \. Subject 22 years of age or older on the date of informed consent 2. Subject able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Subjects presenting at the site with normal eyes. Cataracts, LASIK, PRK, and peripheral pathology that does not affect the posterior pole region, for example lattice and peripheral drusen, are allowed.
- \. BCVA 20/40 or better (each eye) 5. Subject is able to comply with the study procedures
You may not qualify if:
- \. Subject unable to tolerate ophthalmic imaging 2. Subject has an ocular pathology other than cataract or mild peripheral, age-related changes (e.g., peripheral drusen, lattice, etc.) 3. Glaucoma diagnosis in either eye. 4. Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 5. Subject with ocular media not sufficiently clear to obtain acceptable OCT images
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Intalight, Inclead
- Illinois College of Optometrycollaborator
Study Sites (3)
New View Optometry
San Diego, California, 91942, United States
Illinois College of Optometry
Chicago, Illinois, 60616, United States
Indiana University - School of Optometry
Bloomington, Indiana, 47405, United States
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 7, 2026
Study Start
July 8, 2026
Primary Completion (Estimated)
September 15, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
August 7, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
All data will be kept confidential to the site and the Sponsor